Another report showed that TFAP2A mediates SUMO pathway inhibition in breast cancer, indicating that TFAP2A may act as an upstream regulator of the SUMO pathway to regulate global SUMO modification in tumor cells and thus influence the cellular phenotype (111). The gene discussed is TFAP2A; the disease is breast carcinoma.